IFP Exclusive

Iran Testing Own Version of ‘Actemra’ to Treat COVID-19

Iran’s Health Ministry spokesman says the application of an indigenized version of Roche’s “Actemra” medicine has resulted in relative improvement of symptoms in some serious cases of coronavirus infections, but it is too soon to make any judgment.

Kianoush Jahanpour confirmed in an interview with ISNA on Wednesday that an Iranian version of the Swiss-made “Actemra” which regulates the immune system has been used at one of Isfahan’s hospitals and that a relative improvement in the patient’s symptoms has been observed.

“This has been the first case trial of the Persian biosimilar tocilizumab and the disease symptoms have improved 48 hours after the usage,” he said.

“But it is too soon to make any judgment,” the official stressed.

“The medicine has shown a relatively positive response 24 hours after the first injection.

Oxygenation in the patient and the chest radiography show better results, but the patient still gets intubated. Today and in next days the trial will continue at doctors’ discretion and if the medicine shows a relative efficacy in the cases, it will enter into the country’s drug list.”

“Some case reports in China indicate their relative efficacy in some serious cases of COVID-19,” said Jahanpour.

The medicine can be mass-produced in a matter of three weeks, he added.

The official, however, emphasized that the medicine cannot be generally used, but can be prescribed to those patients in CRS at the last stages of the disease, under certain circumstances.

At the same time, the efficacy of a couple of other biosimilar medicines i.e. interferon alpha and interferon beta, both of which already exist in the country’s drug list, is under consideration, he added.

IFP Editorial Staff

The IFP Editorial Staff is composed of dozens of skilled journalists, news-writers, and analysts whose works are edited and published by experienced editors specialized in Iran News. The editor of each IFP Service is responsible for the report published by the Iran Front Page (IFP) news website, and can be contacted through the ways mentioned in the "IFP Editorial Staff" section.

Recent Posts

Unscheduled visit by Qatari prime minister to Tehran sparks speculation

Reports emerged by Iranian daily Donya-e Eqtesad suggest that the Qatari Prime Minister and Minister…

7 hours ago

ICC issues arrest warrant for Netanyahu, Gallant for ‘war crimes’ in Gaza

The International Criminal Court (ICC) has issued arrest warrants for Israeli Prime Minister Benjamin Netanyahu,…

7 hours ago

Iran to respond to Europe’s “non-technical” move: Foreign Minister

As France, Germany, and the United Kingdom submit an anti-Iran draft resolution to the International…

8 hours ago

President Pezeshkian criticizes western hypocrisy on human rights

During his visit to Sistan and Baluchestan province, Iranian President Masoud Pezeshkian delivered sharp criticism…

8 hours ago

Nearly 90 killed in Israeli attacks on Gaza

Israel has unleashed a series of air attacks on the Gaza Strip that killed nearly…

9 hours ago

Anti-Iran human rights resolution at UNGA politically-motivated: Spokesman

Foreign Ministry Spokesman Esmaeil Baghaei has censured as politically-motivated and unjustified the adoption of a…

9 hours ago